z-logo
open-access-imgOpen Access
Magnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cells
Author(s) -
mingfang Shen,
Baoan Chen,
Jian Cheng,
Feng Gao,
Wenlin Xu,
Hui-lin Shen,
Jia-Hua Ding,
Chong Gao,
Qian Sun,
Xinchen Sun,
Hongyan Cheng,
Guohong Li,
Wenji Chen,
Ning-Na Chen,
Lijie Liu,
Xiaomao Li,
Xuemei Wang
Publication year - 2009
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s5036
Subject(s) - daunorubicin , apoptosis , multiple drug resistance , k562 cells , in vitro , cytotoxic t cell , cancer research , leukemia , caspase 3 , cytotoxicity , pharmacology , chemistry , programmed cell death , drug resistance , biology , immunology , biochemistry , microbiology and biotechnology
Apoptosis is a common pathway that finally mediated the killing functions of anticancer drugs, which is an important cause of multidrug resistance (MDR). The aim of this study was to investigate the potential benefit of combination therapy with magnetic nanoparticle of Fe3O4 (MNP(Fe3O4)) and 5-bromotetrandrin (BrTet). Analysis of the apoptosis percentage showed that combination of daunorubicin (DNR) with either MNP(Fe3O4) or BrTet exerted a potent cytotoxic effect on K562/A02 cells, while MNP(Fe3O4) and BrTet cotreatment can synergistically enhance DNR-induced apoptosis. Importantly, we confirmed that the distinct synergism effect of that composite on reverse multidrug resistance may owe to the regulation of various proliferative and antiapoptotic gene products, including P53 and caspase-3. Thus our in vitro data strongly suggests a potential clinical application of MNP(Fe3O4) and BrTet combination on CML.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom